Given that estrogen is involved in the negative feedback of the HPG axis in those who have undergone central puberty, treatment with an AI could potentially lead to elevated GnRH, LH, and FSH, overstimulation of the ovaries and cyst formation, and even a change in the timing of puberty onset. The gene discussed is GNRH1; the disease is cyst.